Concerning liver steatosis parameters, CAP (fibroscan parameter of NAFLD), FLI, and ALT and γGT blood levels were lower after VLCKD, strongly suggesting favorable effects of VLCKD on NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.